APA

Anderson M. S., Gilmartin J., Cilissen C., De Lepeleire I., Van Bortel L., Dockendorf M. F., Tetteh E., Ancona J. K., Liu R., Guo Y., Wagner J. A. & Butterton J. R. (20160412). Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects. : Antiviral therapy.

Chicago

Anderson Matt S, Gilmartin Jocelyn, Cilissen Caroline, De Lepeleire Inge, Van Bortel Luc, Dockendorf Marissa F, Tetteh Ernestina, Ancona June K, Liu Rachael, Guo Ying, Wagner John A and Butterton Joan R. 20160412. Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects. : Antiviral therapy.

Harvard

Anderson M. S., Gilmartin J., Cilissen C., De Lepeleire I., Van Bortel L., Dockendorf M. F., Tetteh E., Ancona J. K., Liu R., Guo Y., Wagner J. A. and Butterton J. R. (20160412). Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects. : Antiviral therapy.

MLA

Anderson Matt S, Gilmartin Jocelyn, Cilissen Caroline, De Lepeleire Inge, Van Bortel Luc, Dockendorf Marissa F, Tetteh Ernestina, Ancona June K, Liu Rachael, Guo Ying, Wagner John A and Butterton Joan R. Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects. : Antiviral therapy. 20160412.